Case Reports in Infectious Diseases

Case Reports in Infectious Diseases / 2016 / Article

Case Report | Open Access

Volume 2016 |Article ID 2614187 | 2 pages | https://doi.org/10.1155/2016/2614187

First Case Report of Sinusitis with Lophomonas blattarum from Iran

Academic Editor: Daniela M. Cirillo
Received20 Sep 2015
Accepted22 Dec 2015
Published04 Feb 2016

Abstract

Introduction. Lophomonas blattarum is a rare cause of bronchopulmonary and sinus infection. This paper presents a rare case of Lophomonas sinusitis. Case Presentation. The patient was a 31-year-old woman who was admitted because of a history of upper respiratory infection and sinusitis. Direct microscopic examination of the sputum and nasal discharge showed large numbers of living Lophomonas blattarum with irregular movement of flagella. The patient was successfully treated by Metronidazole 750 mg t.i.d. for 30 days. Conclusions. This is the first case report of Lophomonas blattarum sinusitis from Iran.

1. Introduction

Improving society’s overall hygiene level contributes to prevention and control of parasitic infections. However, other factors including insects’ infestation may complicate control and eradication of parasitic infection.

Hypermastigida, together with Trichomonadida, is an order of multi flagellated protozoa belonging to the phylum Parabasalia. This order consists of two suborders: Lophomonadidae and Trichonymphina. Lophomonadidae can be parasitic or symbiotic in the digestive system of termites, cockroaches, and wood roaches [1]. Lophomonas blattarum was first described by S. Stein in 1860, from the gut of the cockroach Blatta orientalis [2]. This protozoan is round to oval shape and 20–60 μm in diameter with an apical tuft of numerous flagella. Lophomonas blattarum is a rare cause of bronchopulmonary infection and respiratory symptoms [2]. Lophomonas blattarum can occasionally infect humans. Only a few articles reported L. blattarum and other flagellated protozoa causing bronchopulmonary infections in humans [35]. These protozoa more commonly infect immunocompromised individuals [6]. Most reported cases are from China and few from Turkey [7, 8]. This report is the first case of L. blattarum human infection in Iran.

2. Case Presentation

The patient was a 31-year-old woman who was admitted on September 13, 2014, because of a history of upper respiratory infection and sinusitis developed rapidly with progressive headache, fever, dizziness, pain of left ear, and sneezing. The nasal discharge and sputum were occasionally green and sticky. Preadmission antibiotic therapy with Cephalexin was not effective. Ear, Nose, and Throat examination revealed congestion and erythema of nose and throat but normal ears. The patient was a lab technician and made direct smears from her nasal discharge and sputum. Surprisingly she observed moving flagellated protozoa.

After referring to our parasitology lab, direct microscopic examinations of the sputum and nasal discharge showed large numbers of living L. blattarum with irregular movement of flagella (Figure 1).

Laboratory examination demonstrated a white blood cell count of 8.7 × 103 per liter 7% eosinophils, ESR of 27, and positive C-Reactive Protein. Microbial culture for detection anaerobics was negative.

Computed tomography (CT) scan of sinuses demonstrated bilateral maxillary mucosal thickening accompanying osteomeatal complex (OMC) obstruction. Mild ethmoidal involvement especially in left side without bone destruction was considered. Other paranasal sinuses were normal in point of pneumatization without any involvement.

There were no respiratory sign and symptoms. Chest X-ray was normal.

The patient was treated with Metronidazole 500 mg b.i.d. for 15 days. Her symptoms were relieved after treatment; however, a few protozoa were found in microscopic direct smears of nasal discharge. Additional treatment with Metronidazole 750 mg t.i.d for 15 days cleared the nasal smear.

3. Discussion

In recent years there has been an increase of reports covering Lophomonas blattarum bronchopulmonary infection, most notably 60 cases from South of China [2]. There were additional cases from other countries including Spain and Turkey [9]. Lophomonas sinusitis, on the other hand, has been rarely reported. This case of Lophomonas sinus infection is the first reported in Iran. Most cases of Lophomonas infection reported in immunocompromised patients [9], but this present case is an immunocompetent patient. Since the real mechanism of transmission has not been clearly described, it is important for clinicians to consider Lophomonas blattarum in their differential diagnosis. Additionally, since similar flagellate has been reported in house dust mite intestine there may be a relationship between respiratory allergy and Lophomonas blattarum or other flagellate [3]. Therefore, in patients with chronic allergy with no response to treatment, Lophomonas infection and Metronidazole treatment may be considered.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

References

  1. S. M. Adl, A. G. B. Simpson, M. A. Farmer et al., “The new higher level classification of eukaryotes with emphasis on the taxonomy of protists,” Journal of Eukaryotic Microbiology, vol. 52, no. 5, pp. 399–451, 2005. View at: Publisher Site | Google Scholar
  2. R. Martinez-Girón and H. C. van Woerden, “Lophomonas blattarum and bronchopulmonary disease,” Journal of Medical Microbiology, vol. 62, no. 11, pp. 1641–1648, 2013. View at: Publisher Site | Google Scholar
  3. R. Martínez-Girón, J. G. Esteban, A. Ribas, and L. Doganci, “Protozoa in respiratory pathology: a review,” The European Respiratory Journal, vol. 32, no. 5, pp. 1354–1370, 2008. View at: Publisher Site | Google Scholar
  4. Y. Wang, Z. Tang, S. Ji et al., “Pulmonary Lophomonas blattarum infection in patients with kidney allograft transplantation,” Transplant International, vol. 19, no. 12, pp. 1006–1013, 2006. View at: Publisher Site | Google Scholar
  5. G.-Z. Yao, L.-Q. Zeng, B. Zhang, and Z.-S. Chang, “Bronchopulmonary Lophomonas blattarum infection: two cases report and literature review,” Zhonghua nei ke za zhi, vol. 47, no. 8, pp. 634–637, 2008. View at: Google Scholar
  6. A. Ribas-Barceló, R. Martínez-Giron, J. Sánchez-Del-Río, and D. González-Alonso, “Protozoal forms in the sputum of immunocompromized patients,” Scandinavian Journal of Infectious Diseases, vol. 37, no. 3, pp. 205–210, 2005. View at: Publisher Site | Google Scholar
  7. X.-M. Nie, X.-P. Yao, Y. Huang, D.-Y. Zhou, Z.-S. Chang, and Q. Li, “Amiodarone pneumonitis with Hypermastigote lung infection: a case report and review of the literatures,” Zhonghua Jie He He Hu Xi Za Zhi, vol. 29, no. 5, pp. 310–312, 2006. View at: Google Scholar
  8. Y. P. Zhou, X. J. Zhu, M. Li, H. Liu, and Y. S. Chen, “Clinical analysis of bronchopulmonary infection with hypermastigotes: a report of two cases and review of the Chinese literature,” Chinese Journal of Tuberculosis and Respiratory Diseases, vol. 29, no. 1, pp. 23–25, 2006. View at: Google Scholar
  9. A. A. Kilimcioglu, Y. Havlucu, N. Girginkardesler, P. Çelik, K. Yereli, and A. Özbilgin, “Putative bronchopulmonary flagellated protozoa in immunosuppressed patients,” BioMed Research International, vol. 2014, Article ID 912346, 5 pages, 2014. View at: Publisher Site | Google Scholar

Copyright © 2016 Fariba Berenji et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

1990 Views | 587 Downloads | 1 Citation
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.